Page 105 - AN-2-2

Advanced Neurology Inflammatory myopathies during COVID-19

Acknowledgments Neurographic evidence of inflammatory polyneuropathies
in Peri-COVID-19 circumstances and their relationship
The authors thank Dr. Lana A. Kadhum for her active with acute disease severity and inflammatory storm. Cureus,
efforts in the data collection and sample recruitment. 14: e23517.

Funding https://doi.org/10.7759/cureus.23517
There was no funding from any society or company; the 4. Lundberg IE, Miller FW, Tjärnlund A, et al., 2016, Diagnosis
and classification of idiopathic inflammatory myopathies.
researchers funded their own research.
J Intern Med, 280: 39–51.
Conflict of interest https://doi.org/10.1111/joim.12524
The authors declare that they have no competing interests. 5. Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al.,
2020. Neurologic manifestations in hospitalized patients
Author contributions with COVID-19: The ALBACOVID registry. Neurology, 95:
e1060–e1070.
Conceptualization: Nareen Haikaz Hasrat, Hassan Ala
Farid https://doi.org/10.1212/WNL.0000000000009937
Investigation: Nareen Haikaz Hasrat, Zaineb Adil Yakob 6. Taga A, Lauria G, 2022, COVID-19 and the peripheral
Supervision: Ali Raheem Hashim, Haithem Jawad Kadhum nervous system. A 2-year review from the pandemic to the
Writing – original draft: Nareen Haikaz Hasrat, Hassan Ala vaccine era. J Peripher Nerv Syst, 27: 4–30.
Farid https://doi.org/10.1111/jns.12482
Writing – review & editing: Ali Raheem Hashim, Haithem
Jawad Kadhum, Zaineb Adil Yakob. 7. Hasrat NH, Kadhum HJ, Hashim AR, et al., 2022,
Neurophysiological changes by nerve conduction study
Ethics approval and consent to participate and electromyography in acute and long-term COVID-19
circumstances: A comparative study protocol and review.
The Basrah Health Directorate granted ethical approval J Xian Shiyou Univ, 18: 241–249.
(No. 911) on December 13, 2021, and the Basrah 8. Case Definition for Coronavirus Disease, 2019, (COVID-19),
University College of Medicine’s ethics committee granted as of 3 December 2020. European Centre for Disease
approval (No. 7/9/6292) on December 12, 2021. Patients Prevention and Control. Available from: https://www.ecdc.
who participated in this study provided written informed europa.eu/en/covid-19/surveillance/case-definition [Last
consent. accessed on 2022 Jun 12].

Consent for publication 9. Preston D, Shapiro B, 2020, Electromyography and
Neuromuscular Disorders: Clinical-Electrophysiologic
Written informed consent was obtained from the patients Correlations. 4 ed. Amsterdam: Elsevier Saunders. Available
th
for publication. from: https://www.elsevier.com/books/electromyography-
and-neuromuscular-disorders/978-0-323-66180-5 [Last
Availability of data accessed on 2022 Dec 10].

The datasets used and/or analyzed during the present study 10. Anthony S, Phrathep DD, El-Husari A, et al., 2022, Post-
are available from the corresponding author on reasonable COVID-19 polymyositis: A case report. Cureus, 14: e30991.
request. https://10.7759/cureus.30991
References 11. Hunter K, Lyon MG, 2012, Evaluation and management of
polymyositis. Indian J Dermatol, 57: 371–374.
1. Hashim AR, Kadhum HJ, Farid HA, 2022, The pattern https://doi.org/10.4103/0019-5154.100479
of Covid 19 among hospitalized athletics patient:
A comparative study from Basrah city, Southern Iraq. J Res 12. Gokhale Y, Patankar A, Holla U, et al., 2020, Dermatomyositis
Med Dent Sci, 10: 36–40. during COVID-19 pandemic (A case series): Is there a cause
effect relationship? J Assoc Physicians India, 68: 20–24.
2. Farid HA, Hashim AR, Hasrat NH, et al., 2021, The
neurological manifestations of COVID-19 and their 13. Movahedi N, Ziaee V, 2021, COVID-19 and myositis; true
relationship with the disease severity in hospitalized dermatomyositis or prolonged post viral myositis? Pediatr
patients: A single-centered, cross-sectional study on patients Rheumatol Online J, 19: 86.
with COVID-19 from Basra, Iraq. Multicult Educ, 7: 391. https://doi.org/10.1186/s12969-021-00570-w
https://doi.org/10.5281/zenodo.4730889
14. Saud A, Naveen R, Aggarwal R, et al., 2021, COVID-19 and
3. Hasrat NH, Kadhum HJ, Hashim AR, et al., 2022, myositis: What we know so far. Curr Rheumatol Rep, 23: 63.

Volume 2 Issue 2 (2023) 7 https://doi.org/10.36922/an.378